(19)
(11) EP 1 436 395 A2

(12)

(88) Date of publication A3:
19.02.2004

(43) Date of publication:
14.07.2004 Bulletin 2004/29

(21) Application number: 02776223.6

(22) Date of filing: 16.10.2002
(51) International Patent Classification (IPC)7C12N 15/12, C12N 15/63, C12N 5/00, C07K 14/00
(86) International application number:
PCT/US2002/032917
(87) International publication number:
WO 2003/034028 (24.04.2003 Gazette 2003/17)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 16.10.2001 US 329888 P

(71) Applicant: SmithKline Beecham Corporation
Philadelphia, PA 19101 (US)

(72) Inventors:
  • Blanchard, Steven G.GlaxoSmithKline
    Research Triangle Park, NC 27700 (US)
  • Miller, Aaron BayneGlaxoSmithKline
    Research Triangle Park, NC 27709 (US)
  • Orband-Miller, Lisa A.GlaxoSmithKline
    Research Triangle Park, NC 27709 (US)

(74) Representative: Thornley, Rachel Mary 
GlaxoSmithKlineCorporate Intellectual Property (CN9.25.1)980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)

   


(54) METHODS FOR IDENTIFYING AND USING MODULATORS OF ESTROGEN RELATED RECEPTOR GAMMA